Oliver Distler

Active 1999–2026

365
Papers
44,124
Citations
114
h-index
335
i10-index

Citations

Citations per year for Oliver Distler1978: 1 citations1982: 2 citations1986: 2 citations1998: 6 citations2000: 5 citations2001: 1 citations2002: 9 citations2003: 24 citations2004: 42 citations2005: 66 citations2006: 73 citations2007: 114 citations2008: 159 citations2009: 168 citations2010: 190 citations2011: 227 citations2012: 248 citations2013: 202 citations2014: 287 citations2015: 243 citations2016: 268 citations2017: 329 citations2018: 318 citations2019: 1,559 citations2020: 1,896 citations2021: 2,019 citations2022: 1,871 citations2023: 1,239 citations2024: 2,156 citations2025: 1,029 citations2026: 30 citations1979–1981: no citations, so these years are not shown1983–1985: no citations, so these years are not shown1987–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,734 citing papers, 17.5% of this breakdownChina: 1,624 citing papers, 10.4% of this breakdownItaly: 1,209 citing papers, 7.7% of this breakdownUnited Kingdom: 1,160 citing papers, 7.4% of this breakdownGermany: 1,103 citing papers, 7.1% of this breakdownFrance: 798 citing papers, 5.1% of this breakdownSwitzerland: 617 citing papers, 4% of this breakdownJapan: 543 citing papers, 3.5% of this breakdownNetherlands: 477 citing papers, 3.1% of this breakdownCanada: 475 citing papers, 3% of this breakdownSpain: 397 citing papers, 2.5% of this breakdownAustralia: 356 citing papers, 2.3% of this breakdown
0%17.5%Other 26.4%

Fields

  • Medicine73.6%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Immunology and Microbiology5.8%
  • Engineering1.2%
  • Neuroscience1.2%
  • Health Professions0.4%
  • Other1.9%

Topics

  • Systemic Sclerosis and Related Diseases10.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis6.7%
  • Pulmonary Hypertension Research and Treatments3.9%
  • Inflammatory Myopathies and Dermatomyositis3.3%
  • Rheumatoid Arthritis Research and Therapies2.6%
  • Systemic Lupus Erythematosus Research1.8%
  • Other71.6%

Coauthors

All papers

Open in search
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 cited by 3,406

  2. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 1,613

  3. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 cited by 652

  4. Mapping and predicting mortality from systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 cited by 684

  5. Systemic sclerosis

    Authors: , , , , , , - Nature Reviews Disease Primers 2015 cited by 862

  6. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Claussen, Tobias Lange, Stephan Rosenkranz - European Respiratory Journal 2021 cited by 338

  7. Update of EULAR recommendations for the treatment of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana and 35 more - Annals of the Rheumatic Diseases 2016 cited by 1,116

  8. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2012 cited by 831

  9. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 354

  10. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

    Authors: , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 666

  11. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 cited by 500

  12. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis

    Authors: , , , , , , , , , , , , , - Nature Communications 2017 cited by 347

  13. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia Ulrich, Hans Klose, Martin Claussen, Stephan Eisenmann, Kai‐Helge Schmidt, Andrew J. Swift, A. A. Roger Thompson, Charlie Elliot, Stephan Rosenkranz, Robin Condliffe, David G. Kiely, Michael Halank - The Lancet Respiratory Medicine 2022 cited by 185

  14. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - International Journal of Cardiology 2012 cited by 461

  15. Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 341

  16. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heinrike Wilkens, Hubert Wirtz, Elena Pfeuffer-Jovic, Lars Harbaum, Werner Scholtz, Daniel Dumitrescu, Leonhard Bruch, Gerry Coghlan, Claus Neurohr, Iraklis Tsangaris, Matthias Gorenflo, Laura Scelsi, Anton Vonk Noordegraaf, Silvia Ulrich, Matthias Held - The Journal of Heart and Lung Transplantation 2020 cited by 207

  17. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

    Authors: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 cited by 825

  18. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Journal of Scleroderma and Related Disorders 2017 cited by 521

  19. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Rheumatology 2021 cited by 143

  20. PU.1 controls fibroblast polarization and tissue fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Distler, Georg Schett, Jörg H. W. Distler, Andreas Ramming - Nature 2019 cited by 187

  21. Detect-and-Segment: a Deep Learning Approach to Automate Wound Image Segmentation

    Authors: , , , , , , - Informatics in Medicine Unlocked 2022 cited by 95

  22. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 364

  23. Predictors of progression in systemic sclerosis patients with interstitial lung disease

    Authors: , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 239

  24. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 212